Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4127209

CN1CCN(c2cc3[nH]c(-c4n[nH]cc4NC(=O)N4CCCCC4)nc3cc2F)CC1.O=C(O)C(F)(F)F

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 2/20 0.39
FGFR2 P21802 2/20 0.39
FGFR3 P22607 2/20 0.39
KDR P35968 1/20 0.39
HRH4 Q9H3N8 1/20 0.37
EGLN1 Q9GZT9 2/20 0.35
OPRL1 P41146 1/20 0.34
HTR1A P08908 3/20 0.34
HTR1D P28221 3/20 0.34
HTR1B P28222 3/20 0.34
HTR2C P28335 2/20 0.34
HTR6 P50406 2/20 0.34
WHR1 P49842 1/20 0.34
SRPK1 Q96SB4 1/20 0.33
KMT2A Q03164 1/20 0.33
BMPR1A P36894 1/20 0.33
TGFBR1 P36897 1/20 0.33
ACVRL1 P37023 1/20 0.33
ACVR1 Q04771 1/20 0.33
CYP3A4 P08684 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL4133711 0.98 FGFR1 (0.38) FGFR1FGFR2FGFR3KDRHRH4
SCHEMBL3932241 0.95 FGFR1 (0.42) FGFR1FGFR2FGFR3KDRHRH4
SCHEMBL3934348 0.93 FGFR1 (0.40) FGFR1FGFR2FGFR3KDRHRH4
SCHEMBL3926103 0.87 OPRL1 (0.42) FGFR1FGFR2FGFR3KDREGLN1
SCHEMBL4130323 0.86 FGFR1 (0.41) FGFR1FGFR2FGFR3KDREGLN1
SCHEMBL18833148 0.86 FGFR1 (0.42) FGFR1FGFR2FGFR3KDREGLN1
Hydrochloric Acid SCHEMBL4134109 0.85 FGFR1 (0.40) FGFR1FGFR2FGFR3KDREGLN1
Trifluoroacetic Acid SCHEMBL4130010 0.85 SYK (0.43) FGFR1FGFR2FGFR3KDROPRL1
Trifluoroacetic Acid SCHEMBL4142647 0.85 FGFR1 (0.40) FGFR1FGFR2FGFR3KDREGLN1
Trifluoroacetic Acid SCHEMBL4138498 0.84 SYK (0.41) FGFR1FGFR2FGFR3KDRHRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9126969-B2 Pyrazolylbenzimidazole derivatives, compositions containing them and use thereof AVENTIS PHARMA S.A. (FR) 2015-09-08 US disclosed
US-20090197866-A1 PYRAZOLYLBENZIMIDAZOLE DERIVATIVES, COMPOSITIONS CONTAINING THEM AND USE THEREOF AVENTIS PHARMA S.A. (FR) 2009-08-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090197866-A1 PYRAZOLYLBENZIMIDAZOLE DERIVATIVES, COMPOSITIONS CONTAINING THEM AND USE THEREOF RB1, CCNI, CDK2 FGFR1 2171/4885FGFR2 1805/4885FGFR3 1339/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.